The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The global Biodefense market was valued at US$ 1144 million in 2023 and is anticipated to reach US$ 1884.2 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian Market is the main application, which holds a share about 55%.
This report aims to provide a comprehensive presentation of the global market for Biodefense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodefense.
Report Scope
The Biodefense market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biodefense market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biodefense companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Emergent Biosolutions
- Hytest
- GSK
- Sanofi
- PharmAthene
- Bavarian Nordic
- SIGA Technologies
- Arbutus Biopharma
- DynPort Vaccine
- Xoma Corporation
- Ichor Medical Systems
- Aeolus Pharmaceuticals
- Achaogen
- Elusys Therapeutics
- Dynavax Technologies
- Cleveland BioLabs
- Soligenix
- Alnylam Pharmaceuticals
Segment by Type
- Anthrax
- Smallpox
- Botulism
- Radiation/Nuclear
- Others
Segment by Application
- US Military Market
- US Civilian Market
- Non - US Market
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biodefense companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biodefense Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biodefense Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non - US Market
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biodefense Market Perspective (2019-2030)
2.2 Biodefense Growth Trends by Region
2.2.1 Global Biodefense Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biodefense Historic Market Size by Region (2019-2024)
2.2.3 Biodefense Forecasted Market Size by Region (2025-2030)
2.3 Biodefense Market Dynamics
2.3.1 Biodefense Industry Trends
2.3.2 Biodefense Market Drivers
2.3.3 Biodefense Market Challenges
2.3.4 Biodefense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biodefense Players by Revenue
3.1.1 Global Top Biodefense Players by Revenue (2019-2024)
3.1.2 Global Biodefense Revenue Market Share by Players (2019-2024)
3.2 Global Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biodefense Revenue
3.4 Global Biodefense Market Concentration Ratio
3.4.1 Global Biodefense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biodefense Revenue in 2023
3.5 Biodefense Key Players Head office and Area Served
3.6 Key Players Biodefense Product Solution and Service
3.7 Date of Enter into Biodefense Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biodefense Breakdown Data by Type
4.1 Global Biodefense Historic Market Size by Type (2019-2024)
4.2 Global Biodefense Forecasted Market Size by Type (2025-2030)
5 Biodefense Breakdown Data by Application
5.1 Global Biodefense Historic Market Size by Application (2019-2024)
5.2 Global Biodefense Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biodefense Market Size (2019-2030)
6.2 North America Biodefense Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biodefense Market Size by Country (2019-2024)
6.4 North America Biodefense Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biodefense Market Size (2019-2030)
7.2 Europe Biodefense Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biodefense Market Size by Country (2019-2024)
7.4 Europe Biodefense Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biodefense Market Size (2019-2030)
8.2 Asia-Pacific Biodefense Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biodefense Market Size by Region (2019-2024)
8.4 Asia-Pacific Biodefense Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biodefense Market Size (2019-2030)
9.2 Latin America Biodefense Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biodefense Market Size by Country (2019-2024)
9.4 Latin America Biodefense Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biodefense Market Size (2019-2030)
10.2 Middle East & Africa Biodefense Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biodefense Market Size by Country (2019-2024)
10.4 Middle East & Africa Biodefense Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Detail
11.1.2 Emergent Biosolutions Business Overview
11.1.3 Emergent Biosolutions Biodefense Introduction
11.1.4 Emergent Biosolutions Revenue in Biodefense Business (2019-2024)
11.1.5 Emergent Biosolutions Recent Development
11.2 Hytest
11.2.1 Hytest Company Detail
11.2.2 Hytest Business Overview
11.2.3 Hytest Biodefense Introduction
11.2.4 Hytest Revenue in Biodefense Business (2019-2024)
11.2.5 Hytest Recent Development
11.3 GSK
11.3.1 GSK Company Detail
11.3.2 GSK Business Overview
11.3.3 GSK Biodefense Introduction
11.3.4 GSK Revenue in Biodefense Business (2019-2024)
11.3.5 GSK Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biodefense Introduction
11.4.4 Sanofi Revenue in Biodefense Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 PharmAthene
11.5.1 PharmAthene Company Detail
11.5.2 PharmAthene Business Overview
11.5.3 PharmAthene Biodefense Introduction
11.5.4 PharmAthene Revenue in Biodefense Business (2019-2024)
11.5.5 PharmAthene Recent Development
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Detail
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Biodefense Introduction
11.6.4 Bavarian Nordic Revenue in Biodefense Business (2019-2024)
11.6.5 Bavarian Nordic Recent Development
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Detail
11.7.2 SIGA Technologies Business Overview
11.7.3 SIGA Technologies Biodefense Introduction
11.7.4 SIGA Technologies Revenue in Biodefense Business (2019-2024)
11.7.5 SIGA Technologies Recent Development
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Detail
11.8.2 Arbutus Biopharma Business Overview
11.8.3 Arbutus Biopharma Biodefense Introduction
11.8.4 Arbutus Biopharma Revenue in Biodefense Business (2019-2024)
11.8.5 Arbutus Biopharma Recent Development
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Detail
11.9.2 DynPort Vaccine Business Overview
11.9.3 DynPort Vaccine Biodefense Introduction
11.9.4 DynPort Vaccine Revenue in Biodefense Business (2019-2024)
11.9.5 DynPort Vaccine Recent Development
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Detail
11.10.2 Xoma Corporation Business Overview
11.10.3 Xoma Corporation Biodefense Introduction
11.10.4 Xoma Corporation Revenue in Biodefense Business (2019-2024)
11.10.5 Xoma Corporation Recent Development
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Detail
11.11.2 Ichor Medical Systems Business Overview
11.11.3 Ichor Medical Systems Biodefense Introduction
11.11.4 Ichor Medical Systems Revenue in Biodefense Business (2019-2024)
11.11.5 Ichor Medical Systems Recent Development
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Detail
11.12.2 Aeolus Pharmaceuticals Business Overview
11.12.3 Aeolus Pharmaceuticals Biodefense Introduction
11.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2019-2024)
11.12.5 Aeolus Pharmaceuticals Recent Development
11.13 Achaogen
11.13.1 Achaogen Company Detail
11.13.2 Achaogen Business Overview
11.13.3 Achaogen Biodefense Introduction
11.13.4 Achaogen Revenue in Biodefense Business (2019-2024)
11.13.5 Achaogen Recent Development
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Detail
11.14.2 Elusys Therapeutics Business Overview
11.14.3 Elusys Therapeutics Biodefense Introduction
11.14.4 Elusys Therapeutics Revenue in Biodefense Business (2019-2024)
11.14.5 Elusys Therapeutics Recent Development
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Detail
11.15.2 Dynavax Technologies Business Overview
11.15.3 Dynavax Technologies Biodefense Introduction
11.15.4 Dynavax Technologies Revenue in Biodefense Business (2019-2024)
11.15.5 Dynavax Technologies Recent Development
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Detail
11.16.2 Cleveland BioLabs Business Overview
11.16.3 Cleveland BioLabs Biodefense Introduction
11.16.4 Cleveland BioLabs Revenue in Biodefense Business (2019-2024)
11.16.5 Cleveland BioLabs Recent Development
11.17 Soligenix
11.17.1 Soligenix Company Detail
11.17.2 Soligenix Business Overview
11.17.3 Soligenix Biodefense Introduction
11.17.4 Soligenix Revenue in Biodefense Business (2019-2024)
11.17.5 Soligenix Recent Development
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Detail
11.18.2 Alnylam Pharmaceuticals Business Overview
11.18.3 Alnylam Pharmaceuticals Biodefense Introduction
11.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2019-2024)
11.18.5 Alnylam Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
